Stroke Research Today is a free monthly online journal that collates and summarizes the latest research about Stroke, including details on treatment, recovery, rehabilitation, signs, symptoms.

Volume 1 (2004), Issue 4 (December)

1. Evolution of phonemic word fluency performance in post-stroke aphasia.
   J Commun Disord, 38(2): 83-107. [Abstract] [Full-text]
2. Pure sensory stroke as an isolated manifestation of the lateral medullary infarction.
   J Neuroimaging, 15(1): 82-4. [Abstract] [Full-text]
3. A noninvasive portable acoustic diagnostic system to differentiate ischemic from hemorrhagic stroke.
   J Neuroimaging, 15(1): 57-63. [Abstract] [Full-text]
4. Outcomes in acute ischemic stroke patients without angiographically documented arterial occlusion.
   J Neuroimaging, 15(1): 37-42. [Abstract] [Full-text]
5. Stroke after varicella vaccination.
   J Pediatr, 145(6): 845-7. [Abstract] [Full-text]
6. Effects of velocity on maximal torque production in poststroke hemiparesis.
   Muscle Nerve, 30(6): 732-42. [Abstract] [Full-text]
7. Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project.
   Thromb Haemost, 92(6): 1342-8. [Abstract] [Full-text]
8. Alcohol, wine and mental health: focus on dementia and stroke.
   J Psychopharmacol, 18(4): 449-56. [Abstract] [Full-text]
9. Partial-volume effect on ischemic tissue-fate delineation using quantitative perfusion and diffusion imaging on a rat stroke model.
   Magn Reson Med, 52(6): 1328-35. [Abstract] [Full-text]
10. Family history of stroke among Mexican-American and non-Hispanic white patients with stroke and TIA: implications for the feasibility and design of stroke genetics research.
    Neuroepidemiology, 24(1): 96-102. [Abstract] [Full-text]
11. Frequency and risk factors of vascular cognitive impairment three months after ischemic stroke in china: the Chongqing stroke study.
    Neuroepidemiology, 24(1): 87-95. [Abstract] [Full-text]
12. Comparison of stroke risk factors and outcomes in patients with English-speaking background versus non-English-speaking background.
    Neuroepidemiology, 24(1): 79-86. [Abstract] [Full-text]
13. Seasonal patterns of incidence and case fatality of stroke in Malmo, Sweden: the STROMA study.
    Neuroepidemiology, 24(1): 26-31. [Abstract] [Full-text]
14. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.
    Mol Ther, 11(1): 96-104. [Abstract] [Full-text]
15. In vivo visualization of vascular leakage in photochemically induced cortical infarction.
    J Neurosci Methods, 141(1): 135-41. [Abstract] [Full-text]
16. Dynamic susceptibility contrast-enhanced perfusion MR imaging at 1.5 T predicts final infarct size in a rat stroke model.
    J Neurosci Methods, 141(1): 55-60. [Abstract] [Full-text]
17. The paradigm has shifted to systolic blood pressure.
    J Hum Hypertens, 18: S3-7. [Abstract] [Full-text]
18. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Age Ageing, 34(1): 35-40. [Abstract] [Full-text]
19. What stroke patients want to know and what medical professionals think they should know about stroke: Korean perspectives.
    Patient Educ Couns, 56(1): 85-92. [Abstract] [Full-text]
20. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia.
    Neuroscience, 130(3): 685-96. [Abstract] [Full-text]
21. Middle cerebral artery (MCA) stroke produces dysfunction in adjacent motor cortex as detected by intracortical microstimulation in rats.
    Neuroscience, 130(3): 601-10. [Abstract] [Full-text]
22. Stroke affects the coordination and stabilization of head, thorax and pelvis during voluntary horizontal head motions performed in walking.
    Clin Neurophysiol, 116(1): 101-11. [Abstract] [Full-text]
23. Robust unsupervised segmentation of infarct lesion from diffusion tensor MR images using multiscale statistical classification and partial volume voxel reclassification.
    Neuroimage, 23(4): 1507-18. [Abstract] [Full-text]
24. Spatiotemporal patterns of language-specific brain activity in patients with chronic aphasia after stroke using magnetoencephalography.
    Neuroimage, 23(4): 1308-16. [Abstract] [Full-text]
25. Randomised controlled trial of an occupational therapy intervention to increase outdoor mobility after stroke.
    BMJ, 329(7479): 1372-5. [Abstract] [Full-text]
26. The effectiveness of a modified version of the Wilkinson questionnaire in screening for TIA and minor stroke in the United Kingdom.
    Age Ageing, 34(1): 30-5. [Abstract] [Full-text]
27. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.
    Chest, 126(6): 1938-45. [Abstract] [Full-text]
28. Mechanisms underlying recovery of motor function after stroke.
    Arch Neurol, 61(12): 1844-8. [Abstract] [Full-text]
29. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke.
    Acta Neurol Scand, 111(1): 29-33. [Abstract] [Full-text]
30. Hand coordination following capsular stroke.
    Brain, 128: 64-74. [Abstract] [Full-text]
31. Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans.
    Cereb Cortex, 15(1): 58-63. [Abstract] [Full-text]
32. Risk of myocardial infarction and stroke after acute infection or vaccination.
    N Engl J Med, 351(25): 2611-8. [Abstract] [Full-text]
33. The -148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study.
    J Neurol Neurosurg Psychiatry, 76(1): 121-3. [Abstract] [Full-text]
34. Lesional location of lateral medullary infarction presenting hiccups (singultus).
    J Neurol Neurosurg Psychiatry, 76(1): 95-8. [Abstract] [Full-text]
35. Spontaneous nystagmus in dorsolateral medullary infarction indicates vestibular semicircular canal imbalance.
    J Neurol Neurosurg Psychiatry, 76(1): 88-94. [Abstract] [Full-text]
36. Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke.
    J Neurol Neurosurg Psychiatry, 76(1): 76-81. [Abstract] [Full-text]
37. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator.
    J Neurol Neurosurg Psychiatry, 76(1): 70-5. [Abstract] [Full-text]
38. Changes in cerebral glucose metabolism in newborn infants with cerebral infarction.
    Pediatr Neurol, 32(1): 46-9. [Abstract] [Full-text]
39. Benedikt and "plus-minus lid" syndromes arising from posterior cerebral artery branch occlusion.
    J Neurol Sci, 228(1): 105-7. [Abstract] [Full-text]
40. Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics.
    J Neurol Sci, 228(1): 27-33. [Abstract] [Full-text]
41. Perioperative primary stroke: is aspirin cessation to blame?
    Dermatol Surg, 30(12): 1526-8; discussion 1528-9. [Abstract] [Full-text]
42. Persistent aura without infarction: decription of the first case studied with both brain SPECT and perfusion MRI.
    Cephalalgia, 25(1): 56-9. [Abstract] [Full-text]
43. Thrombomodulin Ala455Val Polymorphism and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study.
    BMC Neurol, 4(1): 21. [Abstract] [Full-text]
44. Relationship between cerebral injury and inflammatory responses in patients undergoing cardiac surgery with cardiopulmonary bypass.
    Cytokine, 29(3): 95-104. [Abstract] [Full-text]
45. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study.
    Eur J Neurol, 12(1): 40-4. [Abstract] [Full-text]
46. Trends in socioeconomic disparities in stroke mortality in six european countries between 1981-1985 and 1991-1995.
    Am J Epidemiol, 161(1): 52-61. [Abstract] [Full-text]
47. A prospective study on cardiovascular events after acute pulmonary embolism.
    Eur Heart J, 26(1): 77-83. [Abstract] [Full-text]
48. Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke.
    J Pineal Res, 38(1): 35-41. [Abstract] [Full-text]
49. Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model.
    Stroke, 36(1): 124-8. [Abstract] [Full-text]
50. Endothelial progenitor cells during cerebrovascular disease.
    Stroke, 36(1): 151-3. [Abstract] [Full-text]
51. Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging.
    Stroke, 36(1): 44-9. [Abstract] [Full-text]
52. Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis.
    Stroke, 36(1): 154-7. [Abstract] [Full-text]
53. Stroke unit care and outcome: results from the 2001 National Sentinel Audit of Stroke (England, Wales, and Northern Ireland).
    Stroke, 36(1): 103-6. [Abstract] [Full-text]
54. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
    Stroke, 36(1): 162-8. [Abstract] [Full-text]
55. The risk and benefit of endarterectomy in women with symptomatic internal carotid artery disease.
    Stroke, 36(1): 27-31. [Abstract] [Full-text]
56. Functional electrical stimulation improves motor recovery of the lower extremity and walking ability of subjects with first acute stroke: a randomized placebo-controlled trial.
    Stroke, 36(1): 80-5. [Abstract] [Full-text]
57. Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats.
    Stroke, 36(1): 129-34. [Abstract] [Full-text]
58. Impaired functional recovery after stroke in the stroke-prone spontaneously hypertensive rat.
    Stroke, 36(1): 135-41. [Abstract] [Full-text]
59. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
    Stroke, 36(1): 62-5. [Abstract] [Full-text]
60. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Stroke, 36(1): 66-73. [Abstract] [Full-text]
61. Optimizing discharge planning: clinical predictors of longer stay after recombinant tissue plasminogen activator for acute stroke.
    Stroke, 36(1): 147-50. [Abstract] [Full-text]
62. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial.
    Stroke, 36(1): 144-6. [Abstract] [Full-text]
63. Cerebral protection during carotid endarterectomy.
    Am J Surg, 188(6): 772-7. [Abstract] [Full-text]
64. Development and implementation of a rapid, accurate, and cost-effective protocol for national stroke prevention screening.
    Am J Surg, 188(6): 638-43. [Abstract] [Full-text]
65. Systemic diseases that cause movement disorders.
    Parkinsonism Relat Disord, 11(1): 1-18. [Abstract] [Full-text]
66. Monocarboxylate transporter expression in the spontaneous hypertensive rat: effect of stroke.
    J Neurosci Res, 79(1): 139-45. [Abstract] [Full-text]
67. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells.
    Glia, 49(3): 407-17. [Abstract] [Full-text]
68. Thalamic thermo-algesic transmission: ventral posterior (VP) complex versus VMpo in the light of a thalamic infarct with central pain.
    Pain, 113(1): 223-32. [Abstract] [Full-text]
69. A novel behavioural registration system LABORAS and the social interaction paradigm detect long-term functional deficits following middle cerebral artery occlusion in the rat.
    Brain Res, 1031(1): 118-24. [Abstract] [Full-text]
70. What MONICA told us about stroke.
    Lancet Neurol, 4(1): 64-8. [Abstract] [Full-text]
71. Accuracy of the ICD-9 codes for identifying TIA and stroke in an Italian automated database.
    Neurol Sci, 25(5): 281-8. [Abstract] [Full-text]
72. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
    Hypertension, 45(1): 46-52. [Abstract] [Full-text]
73. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro.
    Arterioscler Thromb Vasc Biol, 25(1): 222-7. [Abstract] [Full-text]
74. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland.
    Arterioscler Thromb Vasc Biol, 25(1): 228-33. [Abstract] [Full-text]

© 2004-2008 Stroke Research Today. All Rights Reserved.